January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Stay ahead in 2025 with the latest biotech deals. Discover key collaborations, M&A, and strategic moves shaping the ...

While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.